This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Experts
Patricia Shifflett
Senior Vice President & Sector Lead, Health
Contact
PatriciaShifflett@517b2b.comOverview
Patricia Shifflett is a member of the 趣赢平台 Board of Directors and Senior Vice President and Sector Lead, Health. She has 30+ years of experience managing public health programs at the federal, state, and local levels. Shifflett oversees public health research and evaluation projects with special insight into strategic planning and implementation of programs bearing impact on population health outcomes.
Shifflett has held senior management positions with specialties in multisite clinical research coordination; development of clinical and community guidelines; survey design, development, and implementation; and data analytics and evaluation.
Her work focuses on global health and infectious and chronic disease prevention and control with an emphasis in special populations, including pregnant women and children, healthcare providers, and the elderly.
Education
- MS, Organization and Management, Capella University School of Business
- BS, Nursing, Westminster College
-
Opioid prescription and diabetes among Medicare beneficiaries
196,
Diabetes Research and Clinical Practice
January 2023
S.S. Casagrande, A.Z. Beccera, Keith Rust, C.C. Cowie
DOILink for: Opioid prescription and diabetes among Medicare beneficiaries -
Evidence of novel susceptibility variants for prostate cancer and a multiancestry polygenic risk score associated with aggressive disease in men of African ancestry
European Urology
January 2023
F. Chen, R.K. Madduri, A.A. Rodriguez, B.F. Darst, A. Chou, X. Sheng, A. Wang, et al.
DOILink for: Evidence of novel susceptibility variants for prostate cancer and a multiancestry polygenic risk score associated with aggressive disease in men of African ancestry -
Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma
Blood
January 2022
J.E. Flerlage, J.R. Myers, J.L. Maciaszek, N. Oak, S.R. Rashkin, Y. Hui, Y.-D. Wang, et al.
DOILink for: Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma